Cargando…

Systematic evaluation of immune regulation and modulation

Cancer immunotherapies are showing promising clinical results in a variety of malignancies. Monitoring the immune as well as the tumor response following these therapies has led to significant advancements in the field. Moreover, the identification and assessment of both predictive and prognostic bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stroncek, David F., Butterfield, Lisa H., Cannarile, Michael A., Dhodapkar, Madhav V., Greten, Tim F., Grivel, Jean Charles, Kaufman, David R., Kong, Heidi H., Korangy, Firouzeh, Lee, Peter P., Marincola, Francesco, Rutella, Sergio, Siebert, Janet C., Trinchieri, Giorgio, Seliger, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359947/ https://www.ncbi.nlm.nih.gov/pubmed/28331613 http://dx.doi.org/10.1186/s40425-017-0223-8

Ejemplares similares

Human Th17 cells in patients with cancer: Friends or foe?
por: Greten, Tim F., et al.
Publicado: (2012)

Tumour-Associated Transcripts and EGFR Deletion Variants in Colorectal Cancer in Primary Tumour, Metastases and Circulating Tumour Cells
por: Lankiewicz, Silke, et al.
Publicado: (2008)

Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage
por: Eggert, Tobias, et al.
Publicado: (2014)

Primary sterile necrotic cells fail to cross-prime CD8(+) T cells
por: Gamrekelashvili, Jaba, et al.
Publicado: (2012)

Plasticity of Innate Lymphoid Cells in Cancer
por: Heinrich, Bernd, et al.
Publicado: (2022)

Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies
por: Cugno, Chiara, et al.
Publicado: (2015)

Hepatic myeloid-derived suppressor cells in tumor bearing mice exacerbate hepatitis and transform into pro-inflammatory myeloid cells
por: Medina-Echeverz, Jose, et al.
Publicado: (2013)

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
por: Greten, Tim F, et al.
Publicado: (2010)

Molecular therapy for the treatment of hepatocellular carcinoma
por: Greten, T F, et al.
Publicado: (2009)

Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma
por: Heinrich, Bernd, et al.
Publicado: (2022)

Dipeptidyl peptidase 3 and thimet oligopeptidase 1 knockdown support tumor-specific immune responses to whole cell cancer vaccines and tumor cell death in vivo
por: Gamrekelashvili, Jaba, et al.
Publicado: (2013)

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
por: Pittari, Gianfranco, et al.
Publicado: (2015)

Cancer immunotherapy trials: leading a paradigm shift in drug development
por: Emens, Leisha A., et al.
Publicado: (2016)

A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
por: Butterfield, Lisa H, et al.
Publicado: (2008)

MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells
por: Ren, Jiaqiang, et al.
Publicado: (2009)

Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
por: Dhodapkar, Madhav V., et al.
Publicado: (2019)

Immunotherapy biomarkers 2016: overcoming the barriers
por: Gulley, James L., et al.
Publicado: (2017)

Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy
por: Wang, Ena, et al.
Publicado: (2020)

A survey-wide association study to identify youth-specific correlates of major depressive episodes
por: Dhodapkar, Rahul Madhav
Publicado: (2020)

Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention
por: McCachren, Samuel S., et al.
Publicado: (2021)

CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects
por: Slezak, Stefanie L, et al.
Publicado: (2007)

A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma
por: Dhodapkar, Madhav V., et al.
Publicado: (2003)

Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells
por: Dhodapkar, Kavita M., et al.
Publicado: (2002)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies
por: Jin, Ping, et al.
Publicado: (2010)

The immune score as a new possible approach for the classification of cancer
por: Galon, Jérôme, et al.
Publicado: (2012)

Enhancement of clonogenicity of human multiple myeloma by dendritic cells
por: Kukreja, Anjli, et al.
Publicado: (2006)

Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion
por: Ayache, Saleh, et al.
Publicado: (2006)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
por: Costa, Federica, et al.
Publicado: (2018)

Gender disparity in HCC: Is it the fat and not the sex?
por: Greten, Tim F.
Publicado: (2019)

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer
por: Dhodapkar, Kavita M, et al.
Publicado: (2013)

Blood Research: hematology and beyond
por: Stroncek, David F.
Publicado: (2013)

Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis
por: Jin, Ping, et al.
Publicado: (2008)

Interleukin-10 production by effector T cells: Th1 cells show self control
por: Trinchieri, Giorgio
Publicado: (2007)

Regulatory Role of T Cells Producing both Interferon γ and Interleukin 10 in Persistent Infection
por: Trinchieri, Giorgio
Publicado: (2001)

Innate inflammation and cancer: Is it time for cancer prevention?
por: Trinchieri, Giorgio
Publicado: (2011)

Type I interferon: friend or foe?
por: Trinchieri, Giorgio
Publicado: (2010)

Critical role for CX(3)CR1(+) mononuclear phagocytes in intestinal homeostasis
por: Trinchieri, Giorgio
Publicado: (2014)

Biology of Natural Killer Cells
por: Trinchieri, Giorgio
Publicado: (1989)

Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
por: Butterfield, Lisa H, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8e7cg4epnid3ec683a1bm3fkfo